Leukoplakia, oral cavity cancer risk, and cancer survival in the U.S. elderly

Cancer Prevention Research

Volumn 8, Issue 9, 2015, Pages 857-863

  Yanik, Elizabeth L ^a   Katki, Hormuzd A ^a   Silverberg, Michael J ^b   Manos, M Michele ^b   Engels, Eric A ^a   Chaturvedi, Anil K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HUMAN; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES; COHORT ANALYSIS; COMPLICATION; DISEASE COURSE; INCIDENCE; LEUKOPLAKIA, ORAL; MEDICARE; MORTALITY; MOUTH NEOPLASMS; PROPORTIONAL HAZARDS MODEL; REGISTER; REGRESSION ANALYSIS; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; LEUKOPLAKIA, ORAL; MALE; MEDICARE; MOUTH NEOPLASMS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; REGRESSION ANALYSIS; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 84941773537     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-15-0091     Document Type: Article

References (28)

1. American Cancer Society. Cancer facts and figures 2014. Atlanta: American Cancer Society, 2014.
2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods, and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86.
3. Surveillance Epidemiology and End Results Program. SEER Fast Stats. [cited 2014 June 19]. Available from: http://seer.cancer.gov/faststats/selections. php?series=cancer2014
4. Moyer VA. Screening for Oral Cancer: U. S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2014;160:55-60.
5. Dionne KR, Warnakulasuriya S, Binti Zain R, Cheong SC. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory. Int J Cancer 2015;136:503-15.
6. Warnakulasuriya S, Johnson NW, Van Der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Path Med 2007;36:575-80.
7. Cowan CG, Gregg TA, Napier SS, McKenna SM, Kee F. Potentially malignant oral lesions in Northern Ireland: a 20-year population-based perspective of malignant transformation. Oral Dis 2001;7:18-24.
8. Hsue SS, Wang WC, Chen CH, Lin CC, Chen YK, Lin LM. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med 2007;36:25-9.
9. Saito T, Sugiura C, Hirai A, Notani K-I, Totsuka Y, Shindoh M, et al. Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality. Int J Oral Maxillofac Surg 2001;30:49-53.
10. Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 2003;14:47-62.
11. Mehanna HM, Rattay T, Smith J, McConkey CC. Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis. Head Neck 2009;31:1600-9.
12. Silverman S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation: a follow-up study of 257 patients. Cancer 1984;53:563-8.
13. Schepman KP, Van Der Meij EH, Smeele LE, Van Der Waal I. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from the Netherlands. Oral Oncol 1998;34:270-5.
14. Weijers M, Ten Hove I, Allard RH, Bezemer DP, Van Der Waal I. Patients with oral cancer developing from pre-existing oral leukoplakia: do they do better than those with de novo oral cancer? J Oral Pathol Med 2008;37:134-6.
15. Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, et al. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet 2005;365:1927-33.
16. Engels EA, Pfeiffer RM, Ricker W, Wheeler W, Parsons R, Warren JL. Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly. Am J Epidemiol 2011;174:860-70.
17. National Cancer Institute. SEER-Medicare Linked Database. [cited 2014 6/3/14]. Available from: http://healthcaredelivery.cancer.gov/seermedicare
18. Mark SD, Katki HA. Specifying and implementing nonparametric and semiparametric survival estimators in two-stage (sampled) cohort studies with missing case data. J Am Stat Assoc 2006;101:460-71.
19. Lin G, So Y, Johnston G, editors. Analyzing survival data with competing risks using SAS Software. SAS Global Forum 2012 Conference; 2012; Cary, NC: SAS Institute Inc.
20. Korn EL, Graubard BI. Analysis of health surveys. 1st ed. Wiley, editor: Wiley-Interscience; 1999. p. 408.
21. Howlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J, Cronin KA. Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst 2010;102:1584-98.
22. Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol 2006;42:461-74.
23. Day NE. The assessment of lead time and length bias in the evaluation of screening programmes. Maturitas 1985;7:51-8.
24. Sankaranarayanan R, Ramadas K, Thara S, Muwonge R, Thomas G, Anju G, et al. Long term effect of visual screening on oral cancer incidence and mortality in a randomized trial in Kerala, India. Oral Oncol 2013;49:314-21.
25. Pentenero M, Donadini A, Di Nallo E, Maffei M, Marino R, Familiari U, et al. Field effect in oral precancer as assessed by DNA flow cytometry and array-CGH. J Oral Pathol Med 2012;41:119-23.
26. Giaretti W, Maffei M, Pentenero M, Scaruffi P, Donadini A, Di Nallo E, et al. Genomic aberrations in normal appearing mucosa fields distal from oral potentially malignant lesions. Cell Oncol 2012;35:43-52.
27. Brouns ER, Baart JA, Karagozoglu KH, Aartman IH, Bloemena E, Van Der Waal I. Treatment results of CO2 laser vaporisation in a cohort of 35 patients with oral leukoplakia. Oral Dis 2013;19:212-6.
28. Kumar A, Cascarini L, McCaul JA, Kerawala CJ, Coombes D, Godden D, et al. How should we manage oral leukoplakia? Br J Oral Maxillofac Surg 2013;51:377-83.